合全(quan)(quan)藥(yao)(yao)(yao)業是藥(yao)(yao)(yao)明康(kang)德子公(gong)司(si),在亞洲(zhou)、北美及(ji)歐洲(zhou)地區均(jun)設有研(yan)發及(ji)生(sheng)(sheng)產(chan)(chan)基(ji)地。合全(quan)(quan)藥(yao)(yao)(yao)業服務于生(sheng)(sheng)命科學行業,擁有卓(zhuo)越的化(hua)學創(chuang)新藥(yao)(yao)(yao)研(yan)發和生(sheng)(sheng)產(chan)(chan)的能力和技術平臺。作為全(quan)(quan)球新藥(yao)(yao)(yao)合同研(yan)究、開發與(yu)生(sheng)(sheng)產(chan)(chan)領(ling)域(CRDMO)的領(ling)軍企業,合全(quan)(quan)藥(yao)(yao)(yao)業致力于為全(quan)(quan)球合作伙伴提供高效(xiao)、靈活、高質(zhi)量的一站式解決方案,以支持包括小分子、寡核苷酸、多(duo)肽及(ji)各種(zhong)復雜化(hua)學偶聯藥(yao)(yao)(yao)物的研(yan)發與(yu)生(sheng)(sheng)產(chan)(chan)。